Philadelphia, Pa. (July 18, 2013) – Most professional athletes are able to return to competition within a year after vertebral fusion surgery on the upper (cervical) spine, reports a study in the July issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Another study in the July Neurosurgery finds variations in treatment for patients with minor head injuries seen in the emergency department (ED) versus the doctor's office. A third paper discusses the increasing importance of philanthropic funding for neurosurgery research and program development.
When Can Pro Athletes Return to Play after Cervical Spinal Fusion?
Dr. Joseph C. Maroon of University of Pittsburgh Medical Center and colleagues analyzed the treatment and outcomes of one type of cervical spinal fusion surgery, called anterior cervical discectomy and fusion (ACDF), in 15 professional athletes. The study focused on criteria for making return-to-play (RTP) recommendations.
The patients were eight football players and seven wrestlers. All were cleared for RTP after they had a normal neurological examination and x-rays showing vertebral fusion. Thirteen players returned to their sport within two to twelve months—the average RTP time was six months. Eight athletes are still participating; five retired after competing for another one to three years.
"After a single-level ACDF, an athlete may return to contact sports if there are normal findings on a neurological examination, full range of neck movement, and arthrodesis," Dr. Maroon and coauthors write. They note that athletes undergoing ACDF may be at risk for future spinal degeneration or disease, one level above or below the vertebral fusion.
Variations in Treatment for Minor Head Injuries
Dr. Rebekah Mannix of Children's Hospital Boston and colleagues analyzed national data on more than 10 million health care visits for minor head injuries between 2005 and 2009. These included about 6 million visits to EDs and 4 million to "outpatient" settings—doctors' offices or hospital-based clinics.
Advanced imaging tests (CT or MRI scans) were more often performed for patients seen at EDs: 63 percent, compared to 14 for those seen at doctors' office and 21 percent at hospital clinics. A return visit was arranged for 54 percent of patients at doctors' offices and 29 percent at hospital clinics. Arrangements for follow-up care were made for 67 percent of patients seen at EDs.
Although the study shows variations in care, it permits no conclusions about which type of care is best. Dr. Mannix and coauthors call for further studies of natural recovery after minor head injuries, and how outcomes are affected by different treatment strategies.
Philanthropy for Neurosurgery Research Funding
In a special article, Dr. Edie E. Zusman of Sutter East Bay Neuroscience Institute, Castro Valley, Calif., and colleagues discuss the evolving role of philanthropic funding for neurosurgery research and program development. Such activities have traditionally been funded by government and industry—but as these sources decline, philanthropy has become "an increasingly important mechanism for building, maintaining, and expanding neurosurgical research programs."
The authors discuss some creative approaches to fundraising for research, such as "venture philanthropy" or forming nonprofit foundations and partnerships. In addition to "grateful patients," Dr. Zusman and coauthors conclude, "[C]ollaborations with health organizations, foundations, venture capitalists, and industry can also help to build the research, training, and clinical programs necessary to improve patients' lives."
About Neurosurgery
Neurosurgery, the Official journal of the Congress of Neurological Surgeons, is your most complete window to the contemporary field of neurosurgery. Members of the Congress and non-member subscribers receive 3,000 pages per year packed with the very latest science, technology, and medicine, not to mention full-text online access to the world's most complete, up-to-the-minute neurosurgery resource. For professionals aware of the rapid pace of developments in the field, Neurosurgery is nothing short of indispensable.
About Wolters Kluwer Health
Wolters Kluwer Health is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Serving more than 150 countries and territories worldwide, Wolters Kluwer Health's customers include professionals, institutions and students in medicine, nursing, allied health and pharmacy. Major brands include Health Language®, Lexicomp®, Lippincott Williams & Wilkins, Medicom®, Medknow, Ovid®, Pharmacy OneSource®, ProVation® Medical, and UpToDate®.
Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company. Wolters Kluwer had 2012 annual revenues of €3.6 billion ($4.6 billion), employs approximately 19,000 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Follow our official Twitter handle: @WKHealth.
Journal
Neurosurgery